Princeton Global Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Princeton Global Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,251	Closed	-$25.3K	–	546
2021 Q1	$25K	Hold	1,251	–	–	0.01%	303
2020 Q4	$25K	Buy	1,251 +760	+155%	+$14K	0.01%	307
2020 Q3	$9K	Hold	491	–	–	﹤0.01%	355
2020 Q2	$8K	Buy	+491	New	+$8.42K	﹤0.01%	432

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Princeton Global Asset Management's HQL Position: Q2 2021 in Review

Princeton Global Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2021, closing a stake of 1,251 shares — an estimated $25.3K sold.

Princeton Global Asset Management first reported a position in HQL in Q2 2020 and held it in 4 quarters. The position peaked at $25K in Q1 2021. 67 funds tracked by Wall St. Rank hold HQL as of Q2 2021.

Princeton Global Asset Management reported no remaining abrdn Life Sciences Investors position as of Q2 2021 after selling out during the quarter.
Princeton Global Asset Management sold 1,251 abrdn Life Sciences Investors shares in Q2 2021, an estimated $25.3K.
Princeton Global Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2020 and held it in 4 quarters.
Princeton Global Asset Management's abrdn Life Sciences Investors position peaked at $25K in Q1 2021.
67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2021.

Based on Princeton Global Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.